Clonality of both EGFR and co-occurring TP53 mutations affect the treatment efficacy of the third-generation EGFRTKIs in advanced-stage EGFR-mutant non-small cell lung cancer
ANNALS OF ONCOLOGY（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined